Neometals MD Chris Reed well received by London investors

   Neometals {ASX: NMT}

MD Chris Reed presented to London institutions and investors at the City Investors Circle presentation in the West End of London.

Chris updated the delegates on the current developments and future plans for NMT. He also mentioned the proposed (subject to shareholder approval) de-merger of the Barrambie titanium / vanadium deposit into a newco that will list on the ASX.

 

.

 

.

Neometals {ASX: NMT}

.

MD Chris Reed presented to London institutions and investors at the City Investors Circle presentation in the West End of London.

.

Chris updated the delegates on the current developments and future plans for NMT. He also mentioned the proposed (subject to shareholder approval) de-merger of the Barrambie titanium / vanadium deposit into a newco that will list on the ASX.

.

Chris visits the UK regularly to update shareholders and investors, who have monitored the progress of NMT for several years, and have noted that plans and objectives given in previous visits have been achieved, and shareholder value has increased in spades, from around 2.5 cents to the 27 cents price of today.

.

The Barrambie de-merger, if approved, will give the opportunity for an increase in shareholder value for that project over time, as it sits inside NMT without any attributable value currently.

.

The EGM to approve the Barrambie de-merger will likely be in mid November, so the record date would be around that time, so anyone looking to receive the spin out shares in the newco would need to be aware of the likely qualifying date.

 

 

 

 

 

 

 

 

.